| ACEi | angiotensin-converting-enzyme inhibitors |
| ARB | angiotensin II receptor blockers |
| ARNI | angiotensin receptor/neprilysin inhibitor |
| cGMP | cyclic guanosine monophosphate |
| GDMT | guideline-directed medical therapy |
| HF | heart failure |
| HFmrEF | heart failure with mildly reduced ejection fraction |
| HFpEF | heart failure with preserved ejection fraction |
| HFrEF | heart failure with reduced ejection fraction |
| LA | left atrium |
| KCCQ | Kansas City Cardiomyopathy Questionnaire |
| MRA | mineralocorticoid receptor antagonist |
| NO–sGC–cGMP | nitric oxide–soluble guanylate cyclase–cyclic guanosine monophosphate |
| NT-proBNP | N-terminal prohormone of brain natriuretic peptide |
| sGC | soluble guanylate cyclase |
| SGLT2 | sodium–glucose cotransporter 2 |